Abdominal venous thrombosis in neonates and infants: Role of prothrombotic risk factors - A multicentre case-control study

British Journal of Haematology

Volumn 111, Issue 2, 2000, Pages 534-539

  Robbie, L A ^a,b   Bennett, B ^b   Keyt, B A ^c   Booth, N A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c GENENTECH INC   (United States)

Author keywords

Hepatic vein thrombosis; Infancy; Portal vein thrombosis; Prothrombotic risk factors; Renal vein thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; LIPOPROTEIN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFANT; KIDNEY VEIN THROMBOSIS; LIVER VEIN THROMBOSIS; MALE; MULTICENTER STUDY; NEWBORN; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RISK FACTOR;

ANTIBODIES, ANTICARDIOLIPIN; ANTITHROMBINS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATIC VEIN THROMBOSIS; HOMOCYSTEINE; HUMANS; INFANT; INFANT, NEWBORN; LIPOPROTEIN(A); MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; ODDS RATIO; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PORTAL VEIN; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN S; PROTHROMBIN; RENAL VEINS; VENOUS THROMBOSIS;

EID: 0034528799     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02349.x     Document Type: Article

References (30)

1. Developmental hemostasis: Relevance to thromboembolic complications in pediatric patients
2. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian registry of VTE
3. Prevalence of factor V Leiden in children with thrombo-embolism
4. Mutation in blood coagulation factor V associated with resistance to activated protein C
5. Neonatal renal venous thrombosis in Germany between 1992 and 1994: Epidemiology, treatment and outcome
6. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
7. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis
8. Multicenter evaluation of combined prothrombotic defects associated with thrombophilia in childhood
9. Study of the prothrombin gene 20210 GA variant in FV: Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism
10. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates
11. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
12. Homozygous factor V Leiden mutation in a child with Budd-Chiari syndrome
13. Does umbilical vein catheterization to exchange transfusion lead to portal vein thrombosis?
14. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia
15. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis
16. Inherited thrombophilia: Part 2
17. Congenital thrombophilia and thrombosis: A study in a single centre
18. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism
19. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: A prospective study
20. Neonatal symptomatic thromboembolism in Germany: Two year survey
21. Increased lipoprotein (a) is an important risk factor for venous thrombosis in childhood
22. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
23. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment
24. Neonatal thrombosis: Report of a prospective Canadian and international registry
25. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis - Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation
26. Umbilical venous catheterization and the risk of portal vein thrombosis
27. Factor V Leiden is not common in children with portal vein thrombosis
28. The aetiology of portal vein thrombosis with particular reference to the role of infection and exchange transfusion
29. Paediatric thrombo-embolism: The influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency
30. Portal vein thrombosis in children: Clinical and laboratory study of 26 cases